Nuclear Pore Complex

Maksym Yezhelyev; Atsuko Fujihara; Michela Casanova; Yataro Daigo; A. Douglas Kinghorn; Y.K.-Y. Chin; Pier Paolo Claudio; Garnet Suck; Amir R. Dehdashti; Antti Vaheri; Andrew M. Fry; Annette Schmitt‐Graeff; Stephen R. Grobmyer; Nobutaka Iwakuma; Sonia Mohinta; Patricia S. Steeg; Joseph R. DiFranza; Kounosuke Watabe; Werner Held; Paola Collini; James F. Gusella; Rafael Rosell; Ruth O’Regan; Juha Peltonen; Sun Zhi-fu; Delvys Rodríguez‐Abreu; Dirk Rades; Sirkku Peltonen; Akira Nakagawara; Martin Digweed; Andrea C. Ferrari; Sidney Croul; Hitoshi Ikeda; Kota V. Ramana; Vesa Aaltonen; Gary H. Lyman; Abhijit Guha; Gautam Chaudhuri; I. Durán; Ellen Weisberg; Joseph R. Landolph; Ping Yang; Jong‐Heun Lee; Maxwell Summerhayes; Christine E. Horak; Charles L. Vogel; Manfred Schwab; Lillian L. Siu; Satish K. Srivastava; David Denning

Nuclear Pore Complex

Maksym Yezhelyev, Atsuko Fujihara, Michela Casanova(Fondazione IRCCS Istituto Nazionale dei Tumori), Yataro Daigo(The University of Tokyo), A. Douglas Kinghorn(The Ohio State University), Y.K.-Y. Chin, Pier Paolo Claudio(Temple University), Garnet Suck, Amir R. Dehdashti(Northwell Health), Antti Vaheri(University of Helsinki), Andrew M. Fry(University of Leicester), Annette Schmitt‐Graeff, Stephen R. Grobmyer, Nobutaka Iwakuma, Sonia Mohinta, Patricia S. Steeg(National Cancer Institute), Joseph R. DiFranza(University of Massachusetts Chan Medical School), Kounosuke Watabe(Wake Forest University), Werner Held(Centre National de la Recherche Scientifique), Paola Collini, James F. Gusella(Broad Institute), Rafael Rosell(Hospital Universitario Dexeus), Ruth O’Regan(University of Wisconsin Carbone Cancer Center), Juha Peltonen(University of Helsinki), Sun Zhi-fu, Delvys Rodríguez‐Abreu(Universidad de Las Palmas de Gran Canaria), Dirk Rades(University Hospital Schleswig-Holstein), Sirkku Peltonen(Varsinais-Suomen Sairaanhoitopiiri), Akira Nakagawara(Asia Centre), Martin Digweed(Charité - Universitätsmedizin Berlin), Andrea C. Ferrari(University of Cambridge), Sidney Croul(Dalhousie University), Hitoshi Ikeda, Kota V. Ramana(The University of Texas Medical Branch at Galveston), Vesa Aaltonen, Gary H. Lyman(University of Washington), Abhijit Guha, Gautam Chaudhuri(University of California, Los Angeles), I. Durán(Universidade de Santiago de Compostela), Ellen Weisberg, Joseph R. Landolph(University of Southern California), Ping Yang, Jong‐Heun Lee(Laboratory of Molecular Genetics), Maxwell Summerhayes, Christine E. Horak(Bristol-Myers Squibb (United States)), Charles L. Vogel(Cancer Research Institute), Manfred Schwab(German Cancer Research Center), Lillian L. Siu(University Health Network), Satish K. Srivastava(Baba Raghav Das Medical College), David Denning

Unknown

January 1, 2011

Cited by 1

Related Papers

High-yield production of graphene by liquid-phase exfoliation of graphite

|Nature Nanotechnology|2008|6.2k

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

|The Lancet Oncology|2012|5.5k

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

|New England Journal of Medicine|2014|5.3k

Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes

|Science|1997|4.9k

Nivolumab plus Ipilimumab in Advanced Melanoma

|New England Journal of Medicine|2013|4.2k